two
neutral
human
scfv
identifi
initi
use
elisa
employ
highli
purifi
viru
coat
antigen
biosensor
techniqu
base
imag
ellipsometri
employ
directli
detect
two
neutral
monoclon
antibodi
serial
serum
sampl
sar
patient
volunt
sar
kinet
process
interact
antibodi
sarscov
studi
use
realtim
function
biosensor
biosensor
consist
elisa
antibodi
show
higher
affin
encount
viru
antibodi
affin
antibodi
antibodi
respect
label
free
method
biosensor
base
imag
ellipsometri
prove
compet
mechan
measur
serum
sampl
sar
patient
affin
antibodi
sar
coronaviru
novemb
juli
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
quickli
affect
mani
countri
highli
disrupt
impact
peopl
live
well
economi
recent
sar
outbreak
report
beij
anhui
provinc
china
april
indic
sar
epidem
might
recur
time
futur
peiri
et
al
lingappa
et
al
poutanen
et
al
current
number
sar
vaccin
candid
develop
includ
inactiv
sar
coronaviru
sarscov
vaccin
dna
vaccin
attenu
viru
vaccin
produc
sarscov
specif
protein
bisht
et
al
howev
util
human
remain
unclear
moreov
grave
concern
regard
safeti
antigen
viru
vaccin
might
elicit
antibodi
neutral
oba
et
al
wang
et
al
neutral
sarscov
infect
passiv
immun
antibodi
carri
low
level
risk
compar
method
involv
inactiv
virus
attenu
viru
vector
wang
et
al
ter
meulen
et
al
thu
screen
new
effect
antibodi
deeper
understand
antibodi
respons
viral
compon
viru
imper
accur
diagnosi
ill
develop
vaccin
new
neutral
antibodi
screen
variou
immun
method
avail
detect
presenc
measur
activ
level
key
method
enzymelink
immunosorb
assay
elisa
western
blot
wb
wang
et
al
indirect
fluoresc
antibodi
ifa
wu
et
al
revers
transcriptionpolymeras
chain
reaction
rtpcr
realtim
pcr
poon
et
al
lau
et
al
method
exhibit
vari
strength
weak
method
requir
sampl
label
occasion
result
high
percent
fals
posit
fals
neg
requir
expens
equip
long
et
al
moreov
procedur
discontinu
method
kinet
inform
readili
avail
possibl
mass
transport
limit
yu
et
al
contrast
method
biosensor
imag
ellipsometri
offer
sever
advantag
requir
use
label
rapid
intuitionist
low
cost
furthermor
could
analyz
directli
interact
process
biosensor
techniqu
develop
jin
et
al
protein
analysi
techniqu
abl
engag
swift
autom
multiprotein
analysi
simultan
combin
high
spatial
resolut
imag
ellipsometri
microarray
jin
et
al
jin
et
al
previous
techniqu
use
success
number
scenario
exampl
human
igg
molecul
coval
immobil
wang
jin
hormon
detect
zhao
et
al
cell
factor
receptor
interact
wang
jin
cancer
marker
test
zhang
et
al
quantit
protein
competit
adsorpt
hofmann
et
al
ying
et
al
ying
et
al
kinet
detect
multiprotein
interact
process
jin
et
al
biomolecul
interact
wang
jin
studi
immun
antibodi
phagedisplay
librari
construct
b
cell
sar
convalesc
patient
eighti
clone
select
librari
use
whole
inactiv
sarscov
virion
target
two
human
singl
chain
fv
scfv
character
extens
duan
et
al
duan
et
al
biosensor
util
detect
activ
new
antibodi
sarscov
encount
viru
contrast
serum
sampl
sarsinfect
donor
furthermor
realtim
detect
method
interact
sarscov
new
antibodi
also
investig
silicon
wafer
purchas
gener
research
institut
nonferr
metal
tween
purchas
sigmaaldrich
vv
purchas
acro
glutaraldehyd
aqueou
solut
photograph
gra
bovin
serum
albumin
bsa
purchas
sigma
chemic
use
analyt
grade
antibodi
mw
antibodi
mw
sarscov
provid
institut
biophys
chines
academi
scienc
duan
et
al
duan
et
al
lin
et
al
serum
sampl
sar
patient
isol
day
onset
symptom
provid
depart
epidemiolog
institut
microbiolog
epidemiolog
beij
china
clinic
inform
patient
list
tabl
phosphatebuff
salin
pb
mm
phosphat
nacl
pb
tween
pbst
prepar
deioniz
water
cm
produc
ion
exchang
deminer
follow
pass
milliq
plu
system
millipor
millipor
bedford
realtim
spectroscop
ellipsometri
experi
perform
variabl
angl
spectroscop
ellipsomet
j
woollam
co
microtit
plate
nunc
rochest
ny
coat
overnight
inactiv
sarscov
particl
na
co
ph
block
bsa
pb
incub
individu
phage
scfv
pb
contain
bsa
wash
pbst
bound
antibodi
detect
hrpconjug
antibodi
follow
incub
orthophenylenediamin
opd
substrat
color
reaction
measur
nm
biorad
elisa
reader
hercul
ca
usa
modifi
substrat
silicon
wafer
glutaraldehyd
antibodi
antigen
coval
bound
differ
area
surfac
silicon
wafer
due
reaction
schiff
base
cho
model
microfluid
microarray
case
area
microarray
may
function
immuneprob
immuneprob
captur
correspond
antigen
antibodi
solut
correspond
antibodi
antigen
solut
interact
immuneprob
microarray
form
complex
upon
affin
layer
cover
surfac
area
interact
becom
thicker
surfac
concentr
higher
signific
increas
attach
layer
thick
surfac
concentr
indic
solut
contain
antibodi
antigen
imag
ellipsometri
use
detect
protein
layer
pattern
microarray
surfac
distribut
later
thick
surfac
concentr
protein
layer
pattern
simultan
detect
may
point
exist
antibodi
test
solut
immun
test
bind
process
kinet
process
protein
interact
also
becam
observ
realtim
spectroscop
ellipsometri
import
kinet
data
suppli
use
realtim
experi
imag
ellipsometri
enhanc
standard
singlebeam
ellipsometri
combin
power
ellipsometri
microscopi
jin
et
al
technic
detail
could
found
literatur
wang
jin
arwin
et
al
stenberg
nygren
polish
silicon
wafer
chosen
substrat
silicon
wafer
cut
rectangl
mm
clean
deioniz
water
wafer
surfac
wash
solut
h
h
vv
min
solut
remov
contamin
silicon
surfac
also
improv
number
silanol
group
surfac
thu
make
surfac
hydrophil
rins
deioniz
water
ethanol
wash
surfac
incub
mixtur
apt
vv
absolut
ethanol
absolut
ethanol
vv
h
follow
rins
absolut
ethanol
three
time
reaction
silanol
group
surfac
wafer
result
coval
immobil
osi
oh
ch
nh
form
layer
dens
pack
amino
group
silicon
dioxid
layer
make
surfac
highli
hydrophob
rins
ethanol
pb
wash
surfac
incub
mixtur
glutaraldehyd
aqueou
solut
photograph
gra
pb
glutaraldehyd
pb
vv
h
rins
pb
silicon
wafer
kept
pb
ohc
ch
cho
could
react
nh
osi
oh
ch
nh
made
ch
nch
ch
cho
wang
jin
qualit
detect
serum
antibodi
sarscov
biosensor
base
imag
ellipsometri
sarscov
ligand
immobil
prepar
coval
immobil
six
individu
area
surfac
modifi
silicon
wafer
model
microfluid
microarray
area
requir
sarscov
pass
surfac
modifi
silicon
wafer
wafer
rins
deioniz
water
block
min
room
temperatur
mgml
bsa
six
ident
immuneprob
form
antibodi
dilut
use
pb
solut
tween
concentr
respect
area
requir
antibodi
pass
surfac
immuneprob
six
area
two
control
area
two
area
chosen
detect
antibodi
two
area
chosen
detect
antibodi
antibodi
detect
twice
verifi
immunoreact
within
microarray
rins
deioniz
water
dri
nitrogen
surfac
concentr
surfacebound
antibodi
sarscov
qualit
detect
use
imag
ellipsometri
antibodi
solut
immuneprob
form
complex
layer
area
would
becom
thicker
follow
step
serum
sampl
sar
infect
donor
neg
sampl
detect
use
biosensor
detect
time
estim
around
min
whole
process
requir
approxim
min
kinet
process
analyz
two
antibodi
sarscov
use
realtim
spectroscop
ellipsometri
realtim
observ
interact
antibodi
sar
viru
sarscov
ligand
immobil
prepar
achiev
use
follow
process
modifi
silicon
wafer
incub
min
sarscov
sarscov
coval
immobil
follow
wafer
rins
deioniz
water
surfac
contain
immobil
sarscov
block
use
mgml
bsa
min
chip
insert
reaction
cell
contain
buffer
solut
use
realtim
experi
sens
surfac
clearli
observ
antibodi
dilut
pbst
respect
solut
contain
antibodi
pour
cell
alreadi
contain
buffer
solut
without
antibodi
antibodi
molecul
diffus
sens
surfac
react
correspond
antigen
surfac
result
format
complex
concentr
distribut
antibodi
cell
reach
uniform
bind
process
antigen
surfac
antibodi
solut
observ
simultan
distribut
later
thick
surfac
concentr
protein
layer
pattern
detect
record
everi
correspond
speed
reaction
antibodi
sarscov
bind
process
caus
surfac
concentr
correspond
sens
surfac
increas
time
similar
biacor
techniqu
malmborg
et
al
real
time
experi
perform
accord
fig
detect
activ
antibodi
elisa
contrast
serum
antibodi
od
antibodi
od
serum
sar
patient
od
method
describ
literatur
wang
jin
rate
constant
interact
associ
rate
constant
k
dissoci
rate
constant
k
deriv
analysi
bind
curv
realtim
experi
spectroscop
ellipsometri
interpret
sensorgram
first
order
kinet
assum
associ
constant
given
c
concentr
analyt
r
max
maximum
analyt
bind
capac
biosensor
surfac
r
quantiti
analyt
chip
time
associ
rate
constant
calcul
plot
drdt
r
measur
neg
slope
valu
k
c
k
plot
differ
concentr
antibodyantigen
slope
gave
associ
rate
constant
use
evalu
method
necessari
interact
reach
equilibrium
dissoci
rate
constant
calcul
equat
r
bound
analyt
time
start
dissoci
r
bound
analyt
time
n
affin
constant
calcul
associationdissoci
rate
constant
result
detect
antibodi
antibodi
sar
serum
use
elisa
shown
fig
optic
densiti
od
serum
sar
greatest
od
antibodi
greater
antibodi
result
shown
tabl
fig
imag
grayscal
show
c
correspond
thick
distribut
three
dimens
show
b
signific
increas
layer
thick
appear
bioactiv
area
express
fig
block
mgml
bsa
surfac
concentr
sarscov
layer
surfac
concentr
antibodi
antibodi
serum
sar
patient
respect
result
serial
serum
sampl
sar
patient
neg
serum
sampl
volunt
sar
shown
tabl
fig
result
show
film
thick
posit
sampl
obviou
higher
sarscov
neg
sampl
layer
thick
neg
sampl
layer
posit
interact
similar
sarscov
layer
analyt
sensit
detect
limit
biosensor
found
literatur
zhang
et
al
kinet
process
analysi
antibodi
sarscov
use
realtim
spectroscop
ellipsometri
figur
show
seri
increas
surfac
concentr
allow
bind
process
antibodi
antibodi
sarscov
experi
repeat
sever
time
surfac
concentr
increas
indic
point
antibodi
bind
ligand
affin
two
interact
rate
bind
process
seen
obvious
tabl
thick
antibodi
serum
film
biosensor
base
imag
ellipsometri
time
sarscov
averag
antibodi
serum
thick
nm
sarscov
antibodi
antibodi
serum
sar
result
show
interact
rate
differ
two
bind
process
experiment
result
theoret
analysi
tabl
show
data
detail
analysi
kinet
process
wherebi
antibodi
measur
use
realtim
spectroscop
ellipsomet
affin
sarscov
antibodi
higher
antibodi
demonstr
differ
antibodi
produc
vari
level
affin
antibodi
viru
spot
contain
sarscov
control
fig
bind
process
sarscov
antibodi
obtain
realtim
spectroscop
ellipsomet
thick
increas
nm
within
correspond
surfac
concentr
increas
bind
process
reach
equilibrium
within
min
k
k
k
fig
bind
process
antibodi
sarscov
obtain
realtim
spectroscop
ellipsomet
thick
increas
nm
surfac
concentr
increas
bind
process
reach
equilibrium
within
min
k
k
k
antibodi
antibodi
k
associ
rate
constant
k
dissoci
rate
constant
k
affin
two
antibodi
might
potenti
use
creation
sar
vaccin
diagnosi
sar
examin
activ
two
scfv
fragment
select
phage
display
elisa
reveal
two
scfv
specif
sarscov
similar
level
activ
sarscov
serum
sarsrecov
donor
signific
increas
attach
layer
thick
found
biosensor
provid
indic
interact
process
antibodi
solut
interact
surfac
sarscov
form
complex
point
reinforc
kinet
process
biosensor
base
imag
ellipsometri
valuabl
diagnost
tool
accuraci
diagnosi
compar
method
advantag
biosensor
base
imag
ellipsometri
evid
nt
requir
label
provid
rapid
visual
imag
detect
nonus
label
avoid
unnecessari
disturb
bioactiv
analyt
detect
neutral
antibodi
serum
sampl
sarsinfect
donor
use
biosensor
show
differ
concentr
also
elisa
requir
label
sampl
might
affect
activ
antibodi
presenc
second
antibodi
dye
directli
might
affect
od
elisa
occasion
produc
fals
posit
wang
et
al
biosensor
realtim
analysi
could
detect
directli
thick
antibodi
layer
label
biosensor
demonstr
fact
antibodi
differ
level
activ
encount
viru
addit
biosensor
perform
multipl
test
simultan
thu
biosensor
microarray
much
conveni
analyz
two
antibodi
realtim
analysi
util
intuitionist
experiment
tool
affin
two
antibodi
encount
sarscov
deduc
use
realtim
measur
differ
antibodi
exhibit
differ
level
capac
neutral
sarscov
function
realtim
analysi
suppli
import
kinet
data
interact
rate
affin
condit
etc
kinet
data
provid
import
inform
understand
antigen
immunogen
sarscov
clearli
defin
interact
characterist
ensur
best
antibodi
select
research
tool
assay
compon
two
antibodi
sarscov
prove
effect
antidot
viru
might
practic
applic
beyond
simpl
clinic
diagnosi
antibodi
might
also
use
help
unravel
detail
biolog
mechan
sarscov
identifi
therapeut
target
labelfre
immunolog
method
biosensor
appli
antibodi
interact
sarscov
prove
antibodi
capac
neutral
sarscov
kinet
data
antibodi
sarscov
also
elucid
diseas
mechan
antigen
immunogen
sarscov
therefor
biosensor
valuabl
diagnost
tool
high
accuraci
avail
clinician
concert
convent
test
method
